5585-0282 Screening compound: ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate

5585-0282 Screening compound: ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate
5585-0282 Screening compound: ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate alternative view

Chemical Structure Depiction of ChemDiv screening compound 5585-0282
ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5585-0282

Molecular Formula

C24H37N3O7 (C24 H37 N3 O7)

Compound Name

ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate

IUPAC name

ethyl 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido)acetamido]-3-(4-hydroxyphenyl)propanoate

SMILES

CCOC(C(Cc(cc1)ccc1O)NC(CNC(C(CC(C)C)NC(OC(C)(C)C)=O)=O)=O)=O

InChI

InChI=1S/C24H37N3O7/c1-7-33-22(31)19(13-16-8-10-17(28)11-9-16)26-20(29)14-25-21(30)18(12-15(2)3)27-23(32)34-24(4,5)6/h8-11,15,18-19,28H,7,12-14H2,1-6H3,(H,25,30)(H,26,29)(H,27,32)

InChI Key

IQEIZYLCUWZTPG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00320691

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.57

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

17.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.403

Distribution Coefficient, logD

3.402

Water Solubility, LogSw

-3.46

Polar Surface Area

118.902

Acid Dissociation Constant (pKa)

10.14

Base Dissociation Constant (pKb)

0.69

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

58.33

5585-0282 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Carbonic Anhydrase II Library (4939 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 5585-0282 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5585-0282?
Check Price and Availability of 5585-0282, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5585-0282 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5585-0282
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5585-0282
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5585-0282 available by request